EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+16.08%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$1.69B
AUM Growth
+$1.69B
Cap. Flow
-$21.8M
Cap. Flow %
-1.29%
Top 10 Hldgs %
77.4%
Holding
50
New
6
Increased
5
Reduced
4
Closed
14

Top Buys

1
ITOS icon
iTeos Therapeutics
ITOS
$107M
2
ZYME icon
Zymeworks
ZYME
$71.7M
3
GLPG icon
Galapagos
GLPG
$24.7M
4
VRNA
Verona Pharma
VRNA
$18.9M
5
ALKS icon
Alkermes
ALKS
$14.3M

Top Sells

1
PRTA icon
Prothena Corp
PRTA
$143M
2
SRPT icon
Sarepta Therapeutics
SRPT
$82.5M
3
ORIC icon
Oric Pharmaceuticals
ORIC
$18.3M
4
BEAM icon
Beam Therapeutics
BEAM
$10.3M
5
DNA icon
Ginkgo Bioworks
DNA
$8.34M

Sector Composition

1 Healthcare 99.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCRX icon
26
Pacira BioSciences
PCRX
$1.2B
$10.9M 0.65%
+457,471
New +$10.9M
REPL icon
27
Replimune Group
REPL
$422M
$7.9M 0.47%
850,341
– –
MTSR
28
Metsera, Inc. Common Stock
MTSR
$3.71B
$7.73M 0.46%
271,529
+221,529
+443% +$6.3M
ADAP
29
Adaptimmune Therapeutics
ADAP
$15.6M
$6.57M 0.39%
27,404,070
– –
DAWN icon
30
Day One Biopharmaceuticals
DAWN
$769M
$5.6M 0.33%
862,068
– –
HLVX icon
31
HilleVax
HLVX
$105M
$4.82M 0.29%
+2,420,243
New +$4.82M
ATRA icon
32
Atara Biotherapeutics
ATRA
$84.6M
$4.42M 0.26%
573,183
– –
WHWK
33
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
$2.04M 0.12%
1,091,417
-990,583
-48% -$1.85M
MGNX icon
34
MacroGenics
MGNX
$112M
$1.94M 0.11%
+1,602,717
New +$1.94M
NUVB.WS icon
35
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$1.88M 0.11%
963,333
– –
SRZNW icon
36
Surrozen, Inc. Warrant
SRZNW
$71.6K
$596K 0.04%
66,665
– –
ALGS icon
37
Aligos Therapeutics
ALGS
$73.3M
– –
-88,569
Closed -$731K
BCYC
38
Bicycle Therapeutics
BCYC
$511M
– –
-910,000
Closed -$7.73M
BEAM icon
39
Beam Therapeutics
BEAM
$1.66B
– –
-526,685
Closed -$10.3M
DNA icon
40
Ginkgo Bioworks
DNA
$750M
– –
-1,462,328
Closed -$8.34M
KROS icon
41
Keros Therapeutics
KROS
$618M
– –
-187,500
Closed -$1.91M
PRME icon
42
Prime Medicine
PRME
$578M
– –
-700,000
Closed -$1.39M
PRTA icon
43
Prothena Corp
PRTA
$441M
– –
-11,584,280
Closed -$143M
RLAY icon
44
Relay Therapeutics
RLAY
$619M
– –
-641,426
Closed -$1.68M
SLDB icon
45
Solid Biosciences
SLDB
$427M
– –
-744,450
Closed -$2.75M
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.78B
– –
-1,292,386
Closed -$82.5M
TCRX icon
47
TScan Therapeutics
TCRX
$102M
– –
-662,833
Closed -$915K
VERV
48
DELISTED
Verve Therapeutics
VERV
– –
-1,250,000
Closed -$5.71M
UPB
49
Upstream Bio, Inc. Common Stock
UPB
$923M
– –
-60,000
Closed -$367K
KLRS
50
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
– –
-201,718
Closed -$1.62M
1
2